We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Submission

EPI-7386, a potent N-terminal domain androgen receptor inhibitor, with a favorable preclinical safety and superior in vitro/in vivo profile, in clinical development for prostate cancer

Submitted

197 Views
0 Downloads
0 Saves

Presentation

thumbnail

Abstract

Datasets

No datasets are available for this submission.

Keywords

No keywords are available for this submission

Morressier

Company

Legal

Follow us

© Copyright 2021 Morressier GmbH. All rights reserved.

Morressier

© Copyright 2021 Morressier GmbH.
All rights reserved.